Design issues in pivotal drug trials for drug sensitive tuberculosis (TB)

Author:

Nunn Andrew J.,Phillips Patrick P.J.,Gillespie Stephen H.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference26 articles.

1. Tuberculosis in Kenya: follow-up of the second (1974) national sampling survey and a comparison with the follow-up data from the first (1964) national sampling survey. An East African and British Medical Research Council co-operative investigation?;Tubercle,1979

2. Controlled clinical trial of four short course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report?;East African/British Medical Research Council;Lancet,1974

3. Committee for Medicinal Products for human use: Guideline on the choice of the non-inferiority margin;CPMP,2005

4. Controlled clinical trial of four short course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis?;East African/British Medical Research Council;Lancet,1973

5. Controlled clinical trial of five short course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study?;East African/British Medical Research Council;Am Rev Respir Dis,1981

Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Determining the minimum duration of treatment in tuberculosis: An order restricted non‐inferiority trial design;Pharmaceutical Statistics;2023-07-06

2. Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial;Clinical Infectious Diseases;2022-03-15

3. Clinical Trials of TB: Challenges and Opportunities;Respiratory Disease Series: Diagnostic Tools and Disease Managements;2022

4. Noninferiority Trials;Principles and Practice of Clinical Trials;2022

5. Noninferiority Trials;Principles and Practice of Clinical Trials;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3